The Prognostic Effect of Thrombocytopenia on the Clinical Severity in COVID-19 Patients
Novelty in Biomedicine,
Vol. 14 No. 2 (2026),
6 June 2026
,
Page 97-104
https://doi.org/10.22037/nbm.v14i2.51336
Abstract
Background: Thrombocytopenia is associated with the severity and increased morbidity and mortality of COVID-19. Therefore, understanding this association can aid in diagnosing the disease, predicting outcomes, and reducing mortality and morbidity.
Materials and Methods: Patient data from the teaching hospital's archives were considered. The severity of the disease was classified into four categories: mild, moderate, severe, and very severe, based on the national protocol. A total of 82 patients were analyzed, including 41 with thrombocytopenia and 41 without, who were admitted to the teaching hospital from February 2021 to the end of March 2022. This allowed for a comparative analysis.
Results: Thrombocytopenia was significantly associated with longer hospital stays (p<0.001) of more than 5 days. Thrombocytopenic patients were more likely to be admitted to the ICU (90.2%) compared to non-thrombocytopenic patients (14.6%) (p<0.0001). Thrombocytopenic patients also had lower SpO2, with values below 90% in 90.2% of cases (p=0.046). Thrombocytopenia was linked to DIC and ARDS and had a substantial impact on disease outcome, with mortality rates of 75.6% and 7.3% in thrombocytopenic and non-thrombocytopenic patients, respectively. Severity and various laboratory variables (LDH, D-dimer, CRP, and CPK) also showed significant differences between the two groups. The association between thrombocytopenia and disease severity was significant, with 75.6% categorized as very severe and 22% as severe (p<0.0001).
Conclusion: The study found a clear correlation between hospital stay length and admission location for both patient groups. In the ICU, thrombocytopenic patients experience longer stays and lower SpO2 levels. Thrombocytopenia significantly impacts disease outcome and is closely linked to DIC and ARDS, with an increased risk of mortality. Notable differences exist in LDH, D-dimer, CRP, and CPK levels between the two groups. Thrombocytopenia is associated with higher disease severity, particularly in thrombocytopenic patients. Age, gender, hospital stay length, and disease severity correlate meaningfully. Male patients and those with higher clinical severity tend to have longer stays. Additionally, SpO2 levels, respiratory rate, DIC, disease outcome, CPK, and clinical severity are significantly related.
- Prognostic effect
- Thrombocytopenia
- Severity
- COVID-19
How to Cite
References
1. Phan LT, Nguyen TV, Luong QC, et al. Importation and human-to-human transmission of a novel coronavirus in Vietnam. New England Journal of Medicine. 2020;382(9):872-4.
2. Organization WH, Organization WH. Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19): Geneva; 2020.
3. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507-13.
4. Elasal GM, Mahmoud MM, Aly DE. The Effect of Thrombocytopenia in COVID-19 Patient in Comparison with Patient with Normal Platelets Count. QJM: An International Journal of Medicine. 2023;116(Supplement_1).
5. Mattiuzzi C, Lippi G. Which lessons shall we learn from the 2019 novel coronavirus outbreak? Annals of translational medicine. 2020;8(3).
6. Guan W-j, Ni Z-y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine. 2020;382(18):1708-20.
7. Faisal M, Alzahraa Al-Hattab F, Mohammed Al-boinin A, Mahmoud Al-Qudah B, Waheed MA, Danjuma M. The effects of thrombocytopenia, type 2 diabetes mellitus, and endothelial dysfunction on clinical outcomes in patients with COVID-19. Qatar Medical Journal. 2023;2023(1).
8. Assinger A. Platelets and infection–an emerging role of platelets in viral infection. Frontiers in immunology. 2014;5:649.
9. Drosten C, Seilmaier M, Corman VM, et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. The Lancet infectious diseases. 2013;13(9):745-751.
10. Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clinica chimica acta. 2020;506:145-148.
11. Becker T, Zanchim M, Becker T, et al. Cumulative Fluid Balance and Outcome of Extubation: A Prospective Observational Study from a General Intensive Care Unit. Indian Journal of Critical Care Medicine. 2018;33(1):28-33.
12. Vanderschueren S, De Weerdt A, Malbrain M, et al. Thrombocytopenia and prognosis in intensive care. Critical care medicine. 2000;28(6):1871-6.
13. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA internal medicine. 2020;180(7):934-43.
14. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet. 2020;395(10229):1054-62.
15. Yoon SM, Lee J, Lee S-M, Lee HY. Incidence and clinical outcomes of bacterial superinfections in critically ill patients with COVID-19. Frontiers in Medicine. 2023-March-02 2023;10.
16. Alonso AL, Cox D. Platelet interactions with viruses and parasites. Platelets. 2015;26(4):317-23.
17. Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clinica Chimica Acta. 2020.
18. Yang X, Yang Q, Wang Y, et al. Thrombocytopenia and its association with mortality in patients with COVID‐19. Journal of Thrombosis and Haemostasis. 2020;18(6):1469-72.
19. Hana C, Aboulenain S, Dewaswala N, Narendran V. Does thrombocytopenia truly correlate with COVID-19 severity? Blood. 2020;136:39-40.
20. Akutagawa K, Fujita T, Ouhara K, et al. Glycyrrhizic acid suppresses inflammation and reduces the increased glucose levels induced by the combination of Porphyromonas gulae and ligature placement in diabetic model mice. International Immunopharmacology. 2019;68:30-8.
21. Chen S, Cui G, Peng C, et al. Transplantation of adipose-derived mesenchymal stem cells attenuates pulmonary fibrosis of silicosis via anti-inflammatory and anti-apoptosis effects in rats. Stem cell research & therapy. 2018;9(1):1-12.
22. Sun Z-G, Zhao T-T, Lu N, Yang Y-A, Zhu H-L. Research progress of glycyrrhizic acid on antiviral activity. Mini reviews in medicinal chemistry. 2019;19(10):826-832.
23. Xu C, Fu F, Li X, Zhang S. Mesenchymal stem cells maintain the microenvironment of central nervous system by regulating the polarization of macrophages/microglia after traumatic brain injury. International journal of neuroscience. 2017;127(12):1124-1135.
24. Liu Y, Sun W, Guo Y, et al. Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study. Platelets. 2020;31(4):490-496.
25. Bone RC, Francis PB, Pierce AK. Intravascular coagulation associated with the adult respiratory distress syndrome. Vol 61: Elsevier; 1976:585-589.
26. Peiris JS, Yuen KY, Osterhaus AD, Stöhr K. The severe acute respiratory syndrome. New England Journal of Medicine. 2003;349(25):2431-2441.
27. Chen R-F, Chang J-C, Yeh W-T, et al. Role of vascular cell adhesion molecules and leukocyte apoptosis in the lymphopenia and thrombocytopenia of patients with severe acute respiratory syndrome (SARS). Microbes and infection. 2006;8(1):122-127.
28. Hui P, Cook DJ, Lim W, Fraser GA, Arnold DM. The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest. 2011;139(2):271-8.
29. Wang T, Liu Z, Wang Z, et al. Thrombocytopenia is associated with acute respiratory distress syndrome mortality: an international study. PLoS One. 2014;9(4):e94124.
30. Uğur M, Ayhan E, Bozbay M, et al. The independent association of plateletcrit with long-term outcomes in patients undergoing primary percutaneous coronary intervention. Journal of critical care. 2014;29(6):978-981.
31. Ostrowski SR, Søgaard OS, Tolstrup M, et al. Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis. Front Immunol. 2021;12:779453.
32. Kılıçaslan E, Sayın S, Yıldırım M, et al. Serum Lactate Dehydrogenase Elevates and Inversely Correlates with Platelet Count in Immune Thrombocytopenia: A Case-control Study in Adults. Hamidiye Medical Journal. 2023;4(1).
33. Kiani A, Rahimi F, Afaghi S, et al. The association of serum creatine phosphokinase levels with severity of lung involvement and hypoxia in patients with COVID-19. Biomedical & Biotechnology Research Journal. 2022;6(3).
34. Zhao B, Zheng R. Community-acquired pneumonia complicated by rhabdomyolysis: A clinical analysis of 11 cases. World Journal of Clinical Cases. 2019;7(24):4218.
35. Papageorgiou N, Sohrabi C, Prieto Merino D, et al. High sensitivity troponin and COVID-19 outcomes. Acta Cardiologica. 2022;77(1):81-8.
36. Friedman SA, Charmchi Z, Silver M, Jacoby N, Perk J, Anziska Y. Skeletal Muscle Manifestations and Creatine Kinase in COVID-19. The Neurohospitalist. 2022/10/01 2022;12(4):597-606.
- Abstract Viewed: 32 times
- pdf Downloaded: 28 times